Segment Information (Tables)

3 Months Ended

Dec. 28, 2025

Segment Reporting [Abstract]

Revenues and EBT for reportable segments

The table below presents revenues and EBT for reportable segments (in millions):

	Three Months Ended
	December 28, 2025		December 29, 2024
QCT:
Revenues	$	10,613	$	10,084
Cost of revenues	5,446		5,064
Operating expenses (R&D and SG&A)	1,865		1,774
EBT	$	3,302	$	3,246
QTL:
Revenues	$	1,592	$	1,535
Costs and expenses (1)	361		377
EBT	$	1,231	$	1,158
QSI:
Revenues	$	—	$	—
Operating expenses	3		3
Investment and other income, net	182		22
EBT	$	179	$	19

(1) Substantially all of QTL’s costs and expenses are comprised of operating expenses.

Reconciling items for reportable segments - revenues

Consolidated revenues and EBT include the following reconciling items (in millions):

	Three Months Ended
	December 28, 2025		December 29, 2024
Revenues
Reportable segments	$	12,205	$	11,619
Nonreportable segments	47		50
	$	12,252	$	11,669
EBT
Reportable segments	$	4,712	$	4,423
Nonreportable segments	(85)		—
Unallocated cost of revenues	(82)		(59)
Unallocated R&D expenses	(698)		(598)
Unallocated SG&A expenses	(300)		(189)
Unallocated interest expense	(169)		(163)
Unallocated investment and other income, net	169		221
	$	3,547	$	3,635

Reconciling items for reportable segments - EBT

Consolidated revenues and EBT include the following reconciling items (in millions):

	Three Months Ended
	December 28, 2025		December 29, 2024
Revenues
Reportable segments	$	12,205	$	11,619
Nonreportable segments	47		50
	$	12,252	$	11,669
EBT
Reportable segments	$	4,712	$	4,423
Nonreportable segments	(85)		—
Unallocated cost of revenues	(82)		(59)
Unallocated R&D expenses	(698)		(598)
Unallocated SG&A expenses	(300)		(189)
Unallocated interest expense	(169)		(163)
Unallocated investment and other income, net	169		221
	$	3,547	$	3,635